Posts
August 07 2022
Arcadia Biosciences, Inc. announced the closing of its Registered Direct Offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
August 03 2022
Applied DNA Sciences, Inc. announced the closing of its Public Offering in the amount of $12,000,000. EG&S acted as counsel to the Placement Agent.
August 01 2022
NeoVolta, Inc. announced the closing of its underwritten public offering in the amount of $3,900,000. EGS acted as counsel to Maxim Group LLC, the sole book-running manager for the offering.
July 28 2022
Trevena, Inc. announced the closing of its Registered Direct Offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.
July 26 2022
Client Alert: New York Ramps Up Enforcement of Wage and Harassment Claims
New York employers beware: Governor Hochul has announced that the State will be making it a lot easier for employees to lodge complaints regarding wage violations and workplace sexual harassment and will be ramping up enforcement, including potential criminal penalties.
Click here to read the alert.
July 22 2022
Agile Therapeutics, Inc. announced the closing of its Upsized Public Offering in the amount of $24,000,000. EG&S acted as counsel to the Placement Agent.
July 21 2022
Nuvve Holding Corp. announced the closing of its Registered Direct Offering in the amount of $14,000,000. EG&S acted as counsel to the Placement Agent.
July 20 2022
Kiora Pharmaceuticals, Inc. announced the closing of its Underwritten Offering in the amount of $6,000,000. EG&S acted as counsel to the Underwriter.